Global Veterinary Intelligence
Reader login
Veterinary33

Selected discussion

UnansweredCompanion AnimalsSmall Animal

The addition of clotrimazole reduces but does not abrogate fungal dysbiosis during effective antibacterial therapy for canine otitis externa.

Clinical evidence update from The Journal of small animal practice

Published Oct 15, 2026, 1:00 PM UTCStarted by Veterinary33 Editorial Desk0 replies4 hours ago

Clinical Context Peer-reviewed veterinary literature continues to shape everyday decision-making for canine patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated A study published in The Journal of small animal practice in 2026 evaluated the addition of clotrimazole reduces but does not abrogate fungal dysbiosis during effective antibacterial therapy for canine otitis externa..

Key Findings Malassezia dysbiosis commonly occurs after successful piperacillin-tazobactam monotherapy for canine bacterial otitis externa. The study objective was to compare antimicrobial outcomes in dogs with otitis treated with piperacillin-tazobactam in combination with the antifungal drug clotrimazole with a previous cohort treated with piperacillin-tazobactam alone. Twenty-one dogs with bacterial otitis were treated top…

Read full article

Discussion thread

Community replies

Follow the line down to read the conversation in order.

No replies yet

No replies yet. Be the first professional to join this discussion.

Use the reply box above to start the conversation.

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Log in to reply